Skip to main content
. 2015 Feb 5;26(10):2494–2503. doi: 10.1681/ASN.2014070696

Table 1.

Baseline characteristics by quartiles of urine PIIINP in 958 randomly selected subcohort participants in the CHS

Characteristic Urine PIIINP Quartiles
1 2 3 4
Range (μg/L) ≤1.39 >1.39–2.58 >2.58–4.22 >4.22
n 240 239 240 239
Demographics
 Age±SD, y 78±5 78±5 78±5 79±5
 Male, n (%) 60 (25.0) 81 (33.9) 92 (38.3) 145 (60.7)
 Black, n (%) 29 (12.1) 27 (11.3) 41 (17.1) 49 (20.5)
 Education (>high school), n (%) 83 (34.6) 98 (41.0) 81 (33.8) 90 (37.7)
Lifestyle factors
 Current smoking, n (%) 18 (7.5) 12 (5.0) 23 (9.6) 19 (7.9)
 Alcohol (≥7 drinks/wk), n (%) 28 (11.7) 37 (15.5) 34 (14.2) 20 (8.5)
Prevalent CVD
 History of MI, n (%) 29 (12.1) 31 (13.0) 23 (9.6) 36 (15.1)
 History of HF, n (%) 23 (9.6) 24 (10.0) 13 (5.4) 26 (10.9)
 History of stroke, n (%) 11 (4.6) 15 (6.3) 7 (2.9) 32 (13.4)
Cardiovascular risk factors
 BMI±SD (kg/m2) 26.1±4.4 26.6±4.8 27.6±5.0 27.2±4.6
 SBP±SD (mmHg) 137.6±21.1 137.6±22.3 136.0±20.3 136.1±19.7
 DBP±SD (mmHg) 69.2±10.0 69.8±12.4 69.3±10.8 70.4±11.4
 BP medication use, n (%) 128 (53.3) 141 (59.0) 136 (56.7) 126 (52.7)
 Diabetes, n (%) 20 (8.3) 23 (9.6) 39 (16.3) 51 (21.5)
 Total Chol.±SD (mg/dl) 204.6±36.6 198.6±38.8 205.9±37.6 196.5±41.7
 Lipid medication use, n (%) 32 (13.3) 30 (12.6) 27 (11.3) 26 (10.9)
 CRP (mg/L), median (IQR) 2.3 (1.0–5.1) 1.9 (0.9–3.9) 2.7 (1.1–5.4) 2.5 (1.3–6.4)
 Plasma PIIINP±SD (μg/L) 4.4±1.4 4.7±1.6 4.8±1.4 5.2±1.9
Kidney function measures
 Baseline eGFR±SD (ml/min per 1.73 m2)
  In all participants (n=958) 67.2±16.0 65.3±17.7 63.0±18.3 58.5±20.4
  In those with follow-up eGFR data (n=289) 69.7±15.3 69.0±17.0 65.8±16.6 68.7±19.4
 Follow-up eGFR±SD (ml/min per 1.73 m2) (n=289) 64.6±18.5 60.4±20.4 58.5±20.6 59.3±22.5
 Urine ACR, mg/g (IQR) 6.4 (3.9–13.6) 8.0 (4.7–16.6) 7.5 (4.7–18.2) 12.3 (7.0–52.6)

BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure; Chol., cholesterol; CRP, C-reactive protein; IQR, interquartile range.